2/14
01:32 am
zbh
2/12
09:02 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
2/11
12:50 pm
zbh
Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced [Yahoo! Finance]
2/11
10:59 am
zbh
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Citigroup Inc. from $94.00 to $98.00. They now have a "neutral" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Citigroup Inc. from $94.00 to $98.00. They now have a "neutral" rating on the stock.
2/11
10:24 am
zbh
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $98.00. They now have an "equal weight" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $98.00. They now have an "equal weight" rating on the stock.
2/11
10:13 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "sell" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "sell" rating reaffirmed by analysts at UBS Group AG.
2/11
07:06 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/10
01:32 pm
zbh
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $112.00 price target on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $112.00 price target on the stock.
2/10
01:11 pm
zbh
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/10
01:06 pm
zbh
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle [Seeking Alpha]
Low
Report
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle [Seeking Alpha]
2/10
01:06 pm
zbh
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook [Yahoo! Finance]
Low
Report
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook [Yahoo! Finance]
2/10
01:00 pm
zbh
Zimmer Biomet (NYSE:ZBH) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
2/10
10:33 am
zbh
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript [Yahoo! Finance]
2/10
09:43 am
zbh
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
2/10
08:31 am
zbh
Zimmer Biomet beats quarterly estimates on strong hips, knees device demand [Yahoo! Finance]
Low
Report
Zimmer Biomet beats quarterly estimates on strong hips, knees device demand [Yahoo! Finance]
2/10
07:52 am
zbh
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations [Yahoo! Finance]
Low
Report
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations [Yahoo! Finance]
2/10
06:39 am
zbh
Zimmer Biomet beats top-line and bottom-line estimates; initiates FY26 outlook and new stock repurchase authorization [Seeking Alpha]
Low
Report
Zimmer Biomet beats top-line and bottom-line estimates; initiates FY26 outlook and new stock repurchase authorization [Seeking Alpha]
2/10
06:30 am
zbh
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
Medium
Report
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
2/4
12:33 pm
zbh
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
Low
Report
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
2/3
08:11 pm
zbh
??????????????????: 2032???????3?8765?????????????(CAGR)7.4% [CNET News]
Low
Report
??????????????????: 2032???????3?8765?????????????(CAGR)7.4% [CNET News]
2/3
04:08 am
zbh
3 Reasons ZBH is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons ZBH is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
2/2
10:22 am
zbh
Hip Replacement Market to Reach US$ 11.4 Billion by 2033 Driven by Aging Population, Rising Osteoarthritis, and Robotic-Assisted Surgery Says Astute Analytica [Yahoo! Finance]
Low
Report
Hip Replacement Market to Reach US$ 11.4 Billion by 2033 Driven by Aging Population, Rising Osteoarthritis, and Robotic-Assisted Surgery Says Astute Analytica [Yahoo! Finance]
1/30
12:20 pm
zbh
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and “Inconsistent” Execution
Low
Report
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and “Inconsistent” Execution
1/28
10:58 am
zbh
Zimmer Biomet (NYSE:ZBH) was given a new $86.00 price target on by analysts at UBS Group AG. They now have a "sell" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) was given a new $86.00 price target on by analysts at UBS Group AG. They now have a "sell" rating on the stock.
1/27
06:28 pm
zbh
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
Low
Report
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution